Missense Mutations in the BMP15 Gene Are Associated with Ovarian Failure

Overview

Journal Hum Genet

Specialty Genetics

Date 2006 Mar 2

PMID 16508750

Citations 70

Authors

Hridesh Dixit

Lakshmi K Rao

Venkata V Padmalatha

Murthy Kanakavalli

Mamata Deenadayal

Nalini Gupta

Baidyanath Chakrabarty

Lalji Singh

Affiliations

Soon will be listed here.

Abstract

Premature ovarian failure (POF) is an unexplained amenorrhoea (>6 months) with raised levels of gonadotropins (FSH>40 U/L) occurring before the age of 40 years. Recent studies have elucidated the role of oocyte derived growth factors (BMP15 and GDF9) in maintenance of folliculogenesis, granulosa cell (GC) proliferation and overall fertility. Our recently published work showed presence of two rare missense variants in the GDF9 gene associated with ovarian failure (Dixit et al. 2005, Menopause 12:749-754). The present case-control study has been structured to establish the role of BMP15 germline status associated with ovarian failure. Sequence analysis of the coding region of the BMP15 gene was carried out in a cohort of women with POF (n=133), primary amenorrhoea (n=60), and secondary amenorrhoea (n=9) compared with control females (n=197). This study revealed a total of 18 germline variants in the coding region of BMP15 gene, including 16 novel variants. These novel variants include one intronic variant, one 3' flanking variant, one silent variant, and 13 missense variants. Eleven missense variants were present only in cases with complete absence in the control females. The remaining two missense variants viz. c.308A>G (p.Asn103Ser) and c.788_789insTCT (p.Leu263_Arg264insLeu) were present both in the cases and in the controls. The c.788_789insTCT variant was significantly higher in primary amenorrhoea cases than in the controls (Fisher's exact test, P=0.034). Three frequent variants c.-9C>G, c.308A>G, and c.852C>T were chosen for haplotyping. The haplotype G-G-C was found to be significantly associated with ovarian failure (P=0.0075). In a nutshell, the BMP15 gene is highly associated with etiology of ovarian failure.

Citing Articles

A Novel Homozygous Mutation Causes Ovarian Dysgenesis and Primary Amenorrhea.

Cohen A, Rossetti R, Florsheim N, Samson A, Renbaum P, Carbone E J Endocr Soc. 2025; 9(2):bvae221.

PMID: 39850788 PMC: 11756294. DOI: 10.1210/jendso/bvae221.

Searching for the 'X' factor: investigating the genetics of primary ovarian insufficiency.

Knight A, Sugin S, Jurisicova A J Ovarian Res. 2024; 17(1):238.

PMID: 39609914 PMC: 11603650. DOI: 10.1186/s13048-024-01555-5.

Primary ovarian insufficiency: update on clinical and genetic findings.

Federici S, Rossetti R, Moleri S, Munari E, Frixou M, Bonomi M Front Endocrinol (Lausanne). 2024; 15:1464803.

PMID: 39391877 PMC: 11466302. DOI: 10.3389/fendo.2024.1464803.

The Roles of GDF-9, BMP-15, BMP-4 and EMMPRIN in Folliculogenesis and In Vitro Fertilization.

Fountas S, Petinaki E, Bolaris S, Kargakou M, Dafopoulos S, Zikopoulos A J Clin Med. 2024; 13(13).

PMID: 38999341 PMC: 11242125. DOI: 10.3390/jcm13133775.

Implication of Novel BMP15 and GDF9 Variants in Unexpected Poor Ovarian Response.

Mehdizadeh A, Soleimani M, Amjadi F, Akbari Sene A, Sheikhha M, Dehghani A Reprod Sci. 2023; 31(3):840-850.

PMID: 37848645 DOI: 10.1007/s43032-023-01370-1.

References

Thomas J, Kilpatrick M, Lin K, Erlacher L, Lembessis P, Costa T . Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat Genet. 1997; 17(1):58-64. DOI: 10.1038/ng0997-58. View

Shelling A, Burton K, Chand A, Van Ee C, FRANCE J, Farquhar C . Inhibin: a candidate gene for premature ovarian failure. Hum Reprod. 2000; 15(12):2644-9. DOI: 10.1093/humrep/15.12.2644. View

Di Pasquale E, Beck-Peccoz P, Persani L . Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet. 2004; 75(1):106-11. PMC: 1181993. DOI: 10.1086/422103. View

Liao W, Moore R, Shimasaki S . Functional and molecular characterization of naturally occurring mutations in the oocyte-secreted factors bone morphogenetic protein-15 and growth and differentiation factor-9. J Biol Chem. 2004; 279(17):17391-6. DOI: 10.1074/jbc.M401050200. View

Moore R, Shimasaki S . Molecular biology and physiological role of the oocyte factor, BMP-15. Mol Cell Endocrinol. 2005; 234(1-2):67-73. DOI: 10.1016/j.mce.2004.10.012. View

Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, Amati P . The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet. 2001; 27(2):159-66. DOI: 10.1038/84781. View

Aittomaki K, Lucena J, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J . Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell. 1995; 82(6):959-68. DOI: 10.1016/0092-8674(95)90275-9. View

Bondestam J, Mazerbourg S, Kaivo-Oja N, Groome N, Ritvos O, Hsueh A . Growth differentiation factor-9 stimulates inhibin production and activates Smad2 in cultured rat granulosa cells. Endocrinology. 2002; 144(1):172-8. DOI: 10.1210/en.2002-220618. View

Schlessinger D, Herrera L, Crisponi L, Mumm S, Percesepe A, Pellegrini M . Genes and translocations involved in POF. Am J Med Genet. 2002; 111(3):328-33. DOI: 10.1002/ajmg.10565. View

10.

Yan C, Wang P, DeMayo J, Demayo F, Elvin J, Carino C . Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol. 2001; 15(6):854-66. DOI: 10.1210/mend.15.6.0662. View

11.

Galloway S, McNatty K, Cambridge L, Laitinen M, Juengel J, Jokiranta T . Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet. 2000; 25(3):279-83. DOI: 10.1038/77033. View

12.

Moore R, Otsuka F, Shimasaki S . Molecular basis of bone morphogenetic protein-15 signaling in granulosa cells. J Biol Chem. 2002; 278(1):304-10. DOI: 10.1074/jbc.M207362200. View

13.

Kaivo-Oja N, Bondestam J, Kamarainen M, Koskimies J, Vitt U, Cranfield M . Growth differentiation factor-9 induces Smad2 activation and inhibin B production in cultured human granulosa-luteal cells. J Clin Endocrinol Metab. 2003; 88(2):755-62. DOI: 10.1210/jc.2002-021317. View

14.

Dixit H, Rao L, Padmalatha V, Kanakavalli M, Deenadayal M, Gupta N . Mutational screening of the coding region of growth differentiation factor 9 gene in Indian women with ovarian failure. Menopause. 2005; 12(6):749-54. DOI: 10.1097/01.gme.0000184424.96437.7a. View

15.

Thomas F, Ethier J, Shimasaki S, Vanderhyden B . Follicle-stimulating hormone regulates oocyte growth by modulation of expression of oocyte and granulosa cell factors. Endocrinology. 2004; 146(2):941-9. DOI: 10.1210/en.2004-0826. View

16.

Takebayashi K, Takakura K, Wang H, Kimura F, Kasahara K, Noda Y . Mutation analysis of the growth differentiation factor-9 and -9B genes in patients with premature ovarian failure and polycystic ovary syndrome. Fertil Steril. 2000; 74(5):976-9. DOI: 10.1016/s0015-0282(00)01539-9. View

17.

Marozzi A, Porta C, Vegetti W, Crosignani P, Tibiletti M, Dalpra L . Mutation analysis of the inhibin alpha gene in a cohort of Italian women affected by ovarian failure. Hum Reprod. 2002; 17(7):1741-5. DOI: 10.1093/humrep/17.7.1741. View

18.

Elvin J, Clark A, Wang P, Wolfman N, Matzuk M . Paracrine actions of growth differentiation factor-9 in the mammalian ovary. Mol Endocrinol. 1999; 13(6):1035-48. DOI: 10.1210/mend.13.6.0310. View

19.

Otsuka F, Yao Z, Lee T, Yamamoto S, Erickson G, Shimasaki S . Bone morphogenetic protein-15. Identification of target cells and biological functions. J Biol Chem. 2000; 275(50):39523-8. DOI: 10.1074/jbc.M007428200. View

20.

McNatty K, Juengel J, Reader K, Lun S, Myllymaa S, Lawrence S . Bone morphogenetic protein 15 and growth differentiation factor 9 co-operate to regulate granulosa cell function in ruminants. Reproduction. 2005; 129(4):481-7. DOI: 10.1530/rep.1.00517. View